KZR Stock Analysis: Buy, Sell, or Hold?
KZR - Kezar Life Sciences, Inc. Common Stock
$7.44
1.24 (20.00%)
▲
5d:
+15.71%
30d:
+11.04%
90d:
+17.35%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Mar 31, 2026
TODAY
Smart Money Accumulation
KZR is down 4.5% this week, but smart money is accumulating calls. Top strike: $7.5 2026-04-17 with 1,627 OI. Call ratio: 96% View Scanner →
Strength: 6.8/10
Get Alerted When KZR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KZR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: KZR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: KZR is currently trading at $7.44, which is considered extended relative to its 30-day fair value range of $6.52 to $7.10.
Technical Outlook: Technically, KZR is in a uptrend. The price is approaching resistance at $7.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 20.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KZR is in a uptrend. The price is approaching resistance at $7.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 20.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$6.52 -
$7.10
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
51.1%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+20.0%)
- NEUTRAL: Near Wall St target ($6.00)
Fair Price Analysis
30-Day Fair Range
$6.52 -
$7.10
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$6.08
Resistance Level
$7.55
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.90
Wall Street Target
$6.00
(-3.2%)
Share & Embed Analysis
Last updated: March 30, 2026 12:11 PM ET
Data refreshes hourly during market hours. Next update: 1:11 PM
Data refreshes hourly during market hours. Next update: 1:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KZR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 54 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 53 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 53 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 60 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 42 HOLD |
